Research · 9 min read
When Software Screens You Before a Clinician Does
Programs say your answers are reviewed, and the word does not say what performed the review. Federal regulation has a defined phrase for the tools that assist a clinical decision, and reading its scope shows how narrow the duty attached to it really is.
Key takeaways
- Federal regulation defines a patient care decision support tool as any automated or non-automated tool, mechanism, method, technology or combination used to support clinical decision-making.
- The duty attached to it is a nondiscrimination duty — do not discriminate through such tools, identify uses that employ the listed characteristics as inputs, and mitigate the risk.
- Its application section reaches health programs receiving federal financial assistance from the department, administered by the department, or administered by a title one entity — so the test is funding, not medicine.
- Nothing in that rule requires a program to disclose that a tool was used, which is why asking about the sequence before enrolling is the only route available.
- A neighboring section requires a covered entity's information and communication technology to be accessible to individuals with disabilities, and its definition names telehealth interfaces and applications.
- A screening step does not change who holds prescribing authority; that comes from a license and from state law.
Answer first: reviewed is a word about an outcome, not a method
An intake form ends with a sentence about review. Your answers will be reviewed, a clinician will review your information, your request is under review.
Every one of those is true whether a person read your file from the first line or a rule sorted it first and a person confirmed the result.
There is exactly one place in federal regulation where the tools that assist that kind of decision are named and defined. It is a nondiscrimination rule, and it is worth reading for its definition even where its duty does not reach.
The useful move is not suspicion. It is knowing that the word review carries no information about method, and asking a question that does.
The phrase federal regulation actually defines
The defined term is patient care decision support tool. The definition is one sentence and it is deliberately wide.
It means any automated or non-automated tool, mechanism, method, technology, or combination of them used by a covered entity to support clinical decision-making in its health programs or activities.
Read the second and third words again. Non-automated is inside the definition, so a printed cutoff rule or a fixed screening question counts as much as a model does.
That breadth matters more than the technology talk around it. A program does not need anything sophisticated to make a decision by rule rather than by judgment.
The duty attached to the phrase has three parts, and each is written as an effort rather than a result. A covered entity must not discriminate through the use of such tools on the listed grounds.
It has an ongoing duty to make reasonable efforts to identify uses of such tools that employ input variables or factors measuring race, color, national origin, sex, age or disability. And for each tool identified, it must make reasonable efforts to mitigate the resulting risk of discrimination.
Who the rule binds, read to the end
This is where a real citation stops meaning what people assume. The rule's application section names three classes and nothing else.
Every health program or activity, any part of which receives federal financial assistance, directly or indirectly, from the department. Every health program or activity administered by the department. And every health program or activity administered by an entity established under title one of the Affordable Care Act.
The regulation defines a covered entity to match. A recipient of federal financial assistance, the department itself, and a title one entity.
Federal financial assistance is then defined at length. Any grant, loan, credit or subsidy. Any contract other than a procurement contract, including a contract of insurance. And any other arrangement by which the federal government provides assistance in the form of funds, services of federal personnel, or property.
The statute underneath says the same in its own words. Its prohibition attaches to any health program or activity, any part of which is receiving federal financial assistance, including credits, subsidies, or contracts of insurance. It also reaches a program administered by an executive agency or a title one entity.
So the test is the money, not the medicine. Where a program takes none of that, this particular rule is not what governs it, and saying otherwise would be a confident error with a real citation attached.
The neighboring duty, about the software you can see
One section over sits a rule about the technology a patient interacts with rather than the technology that assesses them, and it is worth knowing separately.
A covered entity must ensure its health programs and activities provided through information and communication technology are accessible to individuals with disabilities. The exception is where doing so would cause undue financial and administrative burdens or a fundamental alteration in the nature of the program.
Where that exception applies, the duty does not simply vanish. The entity has to take some other action that avoids the burden or alteration and still gives people with disabilities the benefits of the program to the maximum extent possible.
A second subsection is more specific. A recipient or a state exchange has to ensure that health programs and activities provided through websites and mobile applications comply with the federal disability access provision. That provision is interpreted consistently with the public entities title of the disability act.
The definition of that technology names this market directly. It includes computers, telecommunications equipment, telehealth interfaces or applications, software, mobile applications, websites, videos and electronic documents.
Both duties share the same scope limit. They apply to covered entities, and covered entity is the money test above.
What the rule does not do, even where it applies
It does not ban decision support tools. Nothing in the section says a covered entity may not use one.
It does not require anyone to tell you a tool was used. There is no disclosure duty in the text, no notice to the patient, and no record you can request that says which tool touched your case.
It is not a quality rule either. The duty runs to discrimination on named grounds, not to whether a tool is accurate, well-built or suited to your situation.
And it does not decide who may prescribe. The authority to write a prescription comes from a license and from state law, and no screening step changes that.
The honest summary is narrow. Federal regulation has named these tools and imposed a nondiscrimination duty on a defined class of organizations, and that is the extent of it.
Questions that get a real answer
Since the rules produce no disclosure, the checkable version is what the program will say in writing before you pay.
Ask who performs the first pass over your answers, and whether a licensed clinician reviews every submission or only the ones a screening step flags.
Ask what happens to a submission that falls outside the usual range. A program with a defined path can describe it; one without will describe a review.
Ask for the name and credential of the clinician who makes the decision, and for the entity that holds your file. Those two answers are useful for many reasons beyond this one.
A concrete description is the signal. A program that answers in process terms has given you something to compare against the next program, which is the only comparison available to you.
What this does not settle
It does not say what any program does. No company is named here and no practice is attributed to anyone, because a claim about this market would need a survey of it and there is not one.
It does not say that a screening step is worse than a person reading every line. A consistent rule applied to everyone has real advantages, and a tired reader has real limits.
It does not decide whether the rule described here reaches a program you are considering. That turns on facts about the program's funding that are not usually published.
And it is not advice about your position. This describes what a regulation and a statute say and who they bind, which is a different thing from what follows for you.
Sources
- 45 CFR 92.210, "Nondiscrimination in the use of patient care decision support tools"The general prohibition on a covered entity discriminating on the basis of race, color, national origin, sex, age, or disability in its health programs or activities through the use of patient care decision support tools; the ongoing duty to make reasonable efforts to identify uses of such tools that employ input variables or factors which measure those characteristics; and the duty, for each tool so identified, to make reasonable efforts to mitigate the risk of discrimination resulting from its use. The section contains no disclosure duty, no notice to a patient and no prohibition on using such a tool, which the article states as an absence from the printed text.
- 45 CFR 92.4, "Definitions," and 45 CFR 92.2, "Application"The definition of a patient care decision support tool as any automated or non-automated tool, mechanism, method, technology, or combination thereof used by a covered entity to support clinical decision-making in its health programs or activities; the definition of a covered entity as a recipient of Federal financial assistance, the Department, and an entity established under title I of the Affordable Care Act; the definition of Federal financial assistance as any grant, loan, credit, subsidy, contract other than a procurement contract but including a contract of insurance, or any other arrangement by which the Federal Government directly or indirectly provides assistance in the form of funds, services of Federal personnel, or real or personal property; the definition of information and communication technology, whose listed examples include telehealth interfaces or applications, software, mobile applications and websites; and the application section limiting the part to every health program or activity any part of which receives Federal financial assistance from the Department, every one administered by the Department, and every one administered by a title I entity.
- 45 CFR 92.204, "Accessibility of information and communication technology for individuals with disabilities"That a covered entity must ensure its health programs and activities provided through information and communication technology are accessible to individuals with disabilities unless doing so would result in undue financial and administrative burdens or a fundamental alteration in the nature of the health programs or activities; that where such an alteration or burden would result, the entity shall take any other action that would not, but would nevertheless ensure that to the maximum extent possible individuals with disabilities receive the benefits or services; and that a recipient or State Exchange shall ensure that health programs and activities provided through websites and mobile applications comply with section 504 of the Rehabilitation Act as interpreted consistent with title II of the Americans with Disabilities Act.
- 42 U.S.C. 18116, "Nondiscrimination"That the statutory prohibition attaches to any health program or activity, any part of which is receiving Federal financial assistance, including credits, subsidies, or contracts of insurance, or to any program or activity administered by an Executive Agency or an entity established under that title; that the enforcement mechanisms of the four referenced civil rights statutes apply to violations; that nothing in the title invalidates or limits rights, remedies, procedures or legal standards available under those statutes; that it does not supersede State laws providing additional protections on any basis described; and that the Secretary may promulgate regulations to implement the section, which is the authority the regulations above are issued under.
Frequently asked questions
Is there a federal rule about clinical decision software?
There is one section that names the category. It prohibits a covered entity from discriminating on the basis of race, color, national origin, sex, age or disability through the use of patient care decision support tools. It gives that entity an ongoing duty to make reasonable efforts to identify uses of such tools that employ input variables or factors measuring those characteristics. And it requires reasonable efforts to mitigate the resulting risk for each tool identified. It is a nondiscrimination rule. It is not a safety standard, an approval process, or a rule about whether a person reviewed your case.
What counts as a decision support tool?
More than software. The regulation defines the term as any automated or non-automated tool, mechanism, method, technology, or combination of them used by a covered entity to support clinical decision-making in its health programs or activities. The words automated or non-automated do a lot of work. A printed threshold, a fixed screening question or a scoring sheet fits the definition as squarely as a model does. That is a useful corrective to the assumption that this is only a question about artificial intelligence.
Does that rule apply to a cash-pay telehealth program?
That depends on a fact about the program rather than about the medicine, and the rule says which fact. Its application section reaches three things. A health program or activity any part of which receives federal financial assistance from the department. One administered by the department. And one administered by an entity established under title one of the Affordable Care Act. Federal financial assistance is defined to include grants, loans, credits, subsidies and contracts other than procurement contracts, including contracts of insurance. A program receiving none of those falls outside this rule, and nothing here says whether any particular program does or does not.
Does a program have to tell me if software screened my answers?
Not under this rule. There is no disclosure duty in the text, no notice requirement to the patient, and no record you can request that names the tool. That absence is the practical reason to ask before you enroll rather than after. Three questions get a real answer. Who performs the first pass over your answers, whether a licensed clinician reviews every submission or only flagged ones, and what happens to a submission that falls outside the usual range.
Is there any rule about the app or website itself?
Yes, and it sits one section away. A covered entity must ensure its health programs and activities provided through information and communication technology are accessible to individuals with disabilities. The exception is undue financial and administrative burdens or a fundamental alteration, and even then it must take other action that still delivers the benefits to the maximum extent possible. A recipient or state exchange must also ensure that programs provided through websites and mobile applications comply with the federal disability access provision. The definition of that technology names telehealth interfaces and applications directly.
Would a screening step mean nobody licensed made the decision?
No, and the two questions are separate. The authority to write a prescription comes from a license and from state law, and no screening step alters who holds that authority. What a screening step can change is how much of your file a clinician sees before the decision reaches them, and how a submission that does not fit the usual pattern is handled. That is why the useful question is about the sequence rather than about the technology. A program that can describe its sequence has told you more than one that says your information will be reviewed.